These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6301320)

  • 1. Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation.
    Meyers JD; Leszczynski J; Zaia JA; Flournoy N; Newton B; Snydman DR; Wright GG; Levin MJ; Thomas ED
    Ann Intern Med; 1983 Apr; 98(4):442-6. PubMed ID: 6301320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation.
    Bowden RA; Sayers M; Flournoy N; Newton B; Banaji M; Thomas ED; Meyers JD
    N Engl J Med; 1986 Apr; 314(16):1006-10. PubMed ID: 3007984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus immune plasma in bone marrow transplant recipients.
    Winston DJ; Pollard RB; Ho WG; Gallagher JG; Rasmussen LE; Huang SN; Lin CH; Gossett TG; Merigan TC; Gale RP
    Ann Intern Med; 1982 Jul; 97(1):11-8. PubMed ID: 6283982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of cytomegalovirus infection in bone marrow transplant recipients by prophylaxis with an intravenous, hyperimmune cytomegalovirus globulin.
    Condie RM; O'Reilly RJ
    Birth Defects Orig Artic Ser; 1984; 20(1):327-44. PubMed ID: 6329370
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation.
    Winston DJ; Ho WG; Lin CH; Bartoni K; Budinger MD; Gale RP; Champlin RE
    Ann Intern Med; 1987 Jan; 106(1):12-8. PubMed ID: 3024542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of a polyvalent intravenous immunoglobulin or specific cytomegalovirus hyperimmunoglobulin for modification of cytomegalovirus infections and prevention of interstitial pneumonias following bone marrow transplantation].
    Winston DJ; Ho WG; Lin GH; Bartoni K; Budinger MD; Gale RP; Champlin RE
    Immun Infekt; 1985 Nov; 13(6):296-301. PubMed ID: 3000923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of cytomegalovirus infection by prophylaxis with an intravenous, hyperimmune, native, unmodified cytomegalovirus globulin. Randomized trial in bone marrow transplant recipients.
    Condie RM; O'Reilly RJ
    Am J Med; 1984 Mar; 76(3A):134-41. PubMed ID: 6324587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytomegalovirus hyperimmune globulin prophylaxis in bone marrow transplants in children with various diseases].
    Ebell W; Blütters-Sawatzki R; Friedrich W; Hampl W; Kleihauer E
    Immun Infekt; 1985 Nov; 13(6):307-12. PubMed ID: 3000925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Specific anti-cytomegalovirus immunoglobulins in the prevention of cytomegalovirus infections in bone marrow allografts].
    Huart JJ; Baume D; Jouet JP
    Ann Med Interne (Paris); 1987; 138(5):372-4. PubMed ID: 2823667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation.
    Meyers JD; Reed EC; Shepp DH; Thornquist M; Dandliker PS; Vicary CA; Flournoy N; Kirk LE; Kersey JH; Thomas ED
    N Engl J Med; 1988 Jan; 318(2):70-5. PubMed ID: 2827025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seronegative blood products prevent primary cytomegalovirus infection after bone marrow transplantation.
    Mackinnon S; Burnett AK; Crawford RJ; Cameron S; Leask BG; Sommerville RG
    J Clin Pathol; 1988 Sep; 41(9):948-50. PubMed ID: 2848062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients.
    Snydman DR; Werner BG; Heinze-Lacey B; Berardi VP; Tilney NL; Kirkman RL; Milford EL; Cho SI; Bush HL; Levey AS
    N Engl J Med; 1987 Oct; 317(17):1049-54. PubMed ID: 2821397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients. The Nordic BMT Group.
    Ruutu T; Ljungman P; Brinch L; Lenhoff S; Lönnqvist B; Ringdén O; Ruutu P; Volin L; Albrechtsen D; Sallerfors B; Ebeling F; Myllylä G
    Bone Marrow Transplant; 1997 Feb; 19(3):233-6. PubMed ID: 9028551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune donors can protect marrow-transplant recipients from severe cytomegalovirus infections.
    Grob JP; Grundy JE; Prentice HG; Griffiths PD; Hoffbrand AV; Hughes MD; Tate T; Wimperis JZ; Brenner MK
    Lancet; 1987 Apr; 1(8536):774-6. PubMed ID: 2882184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation.
    Hersman J; Meyers JD; Thomas ED; Buckner CD; Clift R
    Ann Intern Med; 1982 Feb; 96(2):149-52. PubMed ID: 6277215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus (CMV)-specific intravenous immunoglobulin for the prevention of primary CMV infection and disease after marrow transplant.
    Bowden RA; Fisher LD; Rogers K; Cays M; Meyers JD
    J Infect Dis; 1991 Sep; 164(3):483-7. PubMed ID: 1651360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk factors for the occurrence of pneumonia caused by cytomegaloviruses in patients with bone marrow transplants during prevention with cytomegalovirus hyperimmune globulin].
    Schmeiser T; Heit W
    Immun Infekt; 1985 Nov; 13(6):302-6. PubMed ID: 3000924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of cytomegalovirus IgG antibody following infusion of a hyperimmune globulin preparation in allogeneic marrow transplant recipients.
    Reusser P; Osterwalder B; Gratama JW; The TH; Gratwohl A; Speck B
    Bone Marrow Transplant; 1989 May; 4(3):267-72. PubMed ID: 2543469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytomegalovirus hyperimmune globulin and cytomegalovirus-tested blood products--a pilot study in bone marrow graft recipients].
    Beelen DW; Neumann MC; Mahmoud HK; Henneberg K; Thraenhart O; Schaefer UW
    Immun Infekt; 1985 Sep; 13(5):229-32. PubMed ID: 2998980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic use of human leukocyte interferon after allogeneic marrow transplantation.
    Meyers JD; Flournoy N; Sanders JE; McGuffin RW; Newton BA; Fisher LD; Lum LG; Appelbaum FR; Doney K; Sullivan KM
    Ann Intern Med; 1987 Dec; 107(6):809-16. PubMed ID: 2825571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.